← Eichor
Study identifier: NCT04183426 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Tonometry(1) and Duplex Ultrasound(2) to Predict CV Events in to be Treated Patients With an AAA

Condition: Abdominal Aortic Aneurysm · Cardiovascular Events  ·  Sponsor: Rijnstate Hospital

PhaseN/A
Planned participants194
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Abdominal aortic aneurysm (AAA) is a common vascular disease and associated with risk of rupture, but also with a high cardiovascular (CV) event rate. A key difficulty in AAA is predicting these life-threatening complications, which are strongly linked to vascular health. In 2013, the SMART risk score was developed to calculate the risk of the patients for recurrent vascular events based on clinical characteristics. Recently, a novel, easy to perform, non-invasive test of endothelial function (the carotid artery reactivity (CAR) test), reflecting target organ damage, has been introduced. The CAR is a simple, quick (5-min), non-invasive test that uses ultrasound to examine the carotid artery in response to sympathetic stimulation by placing one hand in cold water. This test shows strong agreement with both coronary and aortic responses to sympathetic stimulation and predicted CV-events in patients with peripheral arterial disease. The aim of this prospective 2-year follow-up study is to investigate the predictive capacity of the CAR-test for development of CV-events after elective AAA repair in comparison to the SMART risk score. Secondary objectives are to investigate the predictive capacity of arterial stiffness measurements and the post-operative CAR-test for development of CV-events and to evaluate health status scores to provide insight if these scores can support clinical decision making.

This description comes directly from the study's public registry record.

Talk to the study team

Michel Reijnen, MD, prof  ·  0880057282  ·  MReijnen@rijnstate.nl

Jenske Vermeulen, MSc.  ·  0880057282  ·  JVermeulen@rijnstate.nl

Always discuss trial participation with your own doctor first.

Locations (7)

RadboudumcNijmegen, Gelderland, NetherlandsRecruiting
Canisius Wilhelmina ZiekenhuisNijmegen, Gelderland, NetherlandsRecruiting
Gelre HospitalsApeldoorn, NetherlandsRecruiting
Deventer HospitalDeventer, NetherlandsRecruiting
Ziekenhuis Gelderse ValleiEde, NetherlandsRecruiting
Medisch Spectrum TwenteEnschede, NetherlandsRecruiting
Maxima Medical CenterVeldhoven, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04183426